
<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>TGME49_268860 - Expression Summary</title>
  <style>
    body { font-family: Arial, sans-serif; line-height: 1.6; margin: 20px; }
    h1, h2, h3 { color: #333; }
    table { width: 100%; border-collapse: collapse; margin-bottom: 20px; }
    th, td { border: 1px solid #ddd; padding: 8px; text-align: left; }
    th { background-color: #f4f4f4; }
    img { max-width: 100px; }
    .human-readable { max-width: 50em; }
  </style>
</head>
<body>
  <h1><a href="https://toxodb.org/toxo/app/record/gene/TGME49_268860">TGME49_268860</a> - Bradyzoite-specific expression with dramatic upregulation during chronic infection</h1>
  <div class="human-readable">This gene exhibits <strong>remarkable stage-specific expression</strong> in <i>Toxoplasma gondii</i>, being dramatically upregulated in bradyzoites compared to all other life cycle stages. Expression increases <strong>over 3000-fold during tachyzoite-to-bradyzoite conversion</strong> and reaches extremely high levels (>6000 TPM) in tissue cysts during chronic infection. The gene shows <strong>minimal expression in tachyzoites, merozoites, oocysts, and enteroepithelial stages</strong>, but ranks in the 99th percentile during bradyzoite differentiation across multiple experimental systems. This consistent and dramatic bradyzoite-specific expression pattern suggests the gene likely plays a <strong>critical role in chronic infection biology</strong>, potentially involved in cyst formation, maintenance, or bradyzoite-specific metabolic processes essential for parasite persistence in the host.</div>
  
    <section>
      <h2>Dramatic bradyzoite-specific upregulation across multiple experimental systems</h2>
      <p class="human-readable">The gene shows consistent and dramatic upregulation (3-4000 fold increases) during bradyzoite differentiation across multiple time series experiments, reaching 96-99th percentile expression levels and maintaining high expression in mature bradyzoites both in vitro and in vivo.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_2750122e82" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_2750122e82&default=1"/></td>
<td>Oocyst, tachyzoite, and bradyzoite developmental expression profiles (M4)</td>
<td class="human-readable">This gene shows dramatic upregulation in tachyzoites and bradyzoites (both in vitro and in vivo) compared to oocyst stages in <i>Toxoplasma gondii</i>, with expression levels increasing ~4-fold from oocysts to tachyzoites and ~4-fold again to mature bradyzoites.</td>
<td>5A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/22347997">Fritz and Buchholz et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_994d646c6a" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_994d646c6a&default=1"/></td>
<td>Bradyzoite Differentiation (Multiple 6-hr time points and Extended time series)</td>
<td class="human-readable">This gene is strongly upregulated during <i>Toxoplasma gondii</i> bradyzoite differentiation, showing dramatic increased expression from very low levels at 0 hours (3.5-3.8 log2) to high levels by 2-3 days (10-12 log2) that are maintained through 14 days, indicating it is a bradyzoite-specific or bradyzoite-induced gene.</td>
<td>5A</td>
<td>Davis and Roos et al.</td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_50943f57a2" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_50943f57a2&default=1"/></td>
<td>Bradyzoite Differentiation (3-day time series)(Pru)</td>
<td class="human-readable">This gene is dramatically upregulated during <i>Toxoplasma gondii</i> differentiation from tachyzoites to bradyzoites, showing a 3-fold increase in expression from day 0 to day 2 and maintaining high expression levels through day 4.</td>
<td>5A</td>
<td>Buchholz, Fritz and Boothroyd et al.</td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_35bb13db5b" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_35bb13db5b&default=1"/></td>
<td>Mutants and wild-type expression profiles during bradyzoite differentiation</td>
<td class="human-readable">This gene is strongly upregulated during bradyzoite differentiation in wild-type <i>T. gondii</i>, increasing from ~5 to 12 (log2 expression), but shows severely impaired upregulation in all differentiation mutants, reaching only 5.7-9.8 compared to the wild-type bradyzoite level of 12.</td>
<td>5A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/21209930">Lescault et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_dac07dbf93" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_dac07dbf93&default=1"/></td>
<td>Bradyzoite in vivo transcriptome (M4)</td>
<td class="human-readable">This gene shows extremely high expression in <i>Toxoplasma gondii</i> bradyzoites with 4,092 TPM and a 99.71st percentile ranking, indicating it is among the most highly expressed genes in this developmental stage.</td>
<td>5A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/22021236">Buchholz et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_2daab8c933" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_2daab8c933&default=1"/></td>
<td>Bradyzoite Differentiation Expression Profiles (ME49, GT1, CTGara)</td>
<td class="human-readable">This gene shows strong upregulation during bradyzoite differentiation in <i>Toxoplasma gondii</i>, with particularly marked induction by Compound 1 treatment across all three strain types (GT1, ME49, and CTGara) and substantial upregulation under alkaline pH conditions.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/18433450">Behnke et al.</a></td>
<td>array</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>Strong downregulation in merozoites versus tachyzoites</h2>
      <p class="human-readable">Expression is dramatically reduced in merozoites compared to tachyzoites, with 8-400 fold decreases observed across independent studies, indicating stage-specific suppression during the merozoite phase of the life cycle.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_45b4123102" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_45b4123102&default=1"/></td>
<td>Merozoite Gene Expression</td>
<td class="human-readable">This gene is highly expressed in <i>Toxoplasma gondii</i> tachyzoites (96th percentile) but shows dramatically reduced expression in merozoites from all three cats tested (2nd-5th percentiles), indicating strong stage-specific downregulation during the transition from tachyzoite to merozoite stages.</td>
<td>5A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/24885521">Behnke et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_75742b9a0a" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_75742b9a0a&default=1"/></td>
<td>Tachyzoite and merozoite transcriptomes</td>
<td class="human-readable">This gene is highly upregulated in <i>T. gondii</i> tachyzoites compared to merozoites, with expression levels approximately 400-fold higher in tachyzoites (210.49 TPM) than in merozoites (0.52 TPM).</td>
<td>5A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/25757795">Hehl et al.</a></td>
<td>RNA-Seq</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>Extremely high expression during chronic brain infection</h2>
      <p class="human-readable">The gene shows exceptionally high expression (>4000-6000 TPM, 99th percentile) during chronic infection in mouse brain tissue and maintains stable high levels across extended chronic infection timepoints.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_b0427cd47b" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_b0427cd47b&default=1"/></td>
<td>Transcriptome during acute or chronic infection in mouse brain</td>
<td class="human-readable">This gene shows dramatic upregulation in <i>Toxoplasma gondii</i> during chronic infection (28 days post-infection) compared to acute infection (10 days post-infection), with expression increasing over 40-fold from 93.78 to 3869.65 TPM.</td>
<td>5A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/25240600">Pittman et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_386bac2860" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_386bac2860&default=1"/></td>
<td>T. gondii during spontaneous differentiation in primary rat brain cells.</td>
<td class="human-readable">This gene shows dramatic upregulation during <i>Toxoplasma gondii</i> differentiation in infected rat brain cells, with expression increasing ~30-fold from day 1 to peak levels at day 7 post-infection, while remaining very low in tachyzoites.</td>
<td>5A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/34610266">Mouveaux et al. 2021</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_0d220fc0c6" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_0d220fc0c6&default=1"/></td>
<td>Mouse brain bradyzoite transcriptomes at 28, 90, 120 days post infection</td>
<td class="human-readable">This gene shows consistently very high expression levels (7,461-8,194 TPM) across all time points in <i>Toxoplasma gondii</i> bradyzoites from mouse brain cysts, with minimal variation between 28, 90, and 120 days post-infection.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/31726967">Garfoot et al.</a></td>
<td>RNA-Seq</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>Comprehensive life cycle analysis confirms bradyzoite specificity</h2>
      <p class="human-readable">Full life cycle transcriptome studies demonstrate that this gene has the most dramatic stage-specific expression pattern possible, with tissue cyst expression being 27-fold higher than tachyzoites and over 3000-fold higher than all other life cycle stages.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_e7467c0306" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_e7467c0306&default=1"/></td>
<td>Feline enterocyte, tachyzoite, bradyzoite stage transcriptome</td>
<td class="human-readable">This gene shows dramatically elevated expression in tissue cysts (bradyzoite stage) with over 6000 TPM compared to moderate expression in tachyzoites (~228 TPM) and very low expression across all feline enteroepithelial developmental stages (EES1-5, all <2 TPM).</td>
<td>5A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/30728393">Hehl, Ramakrishnan et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_173528b522" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_173528b522&default=1"/></td>
<td>Full life-cycle transcriptome of T. gondii</td>
<td class="human-readable">This gene shows dramatically elevated expression in tissue cysts (>6000 TPM) compared to all other life cycle stages in <i>Toxoplasma gondii</i>, with moderate expression in tachyzoites (~228 TPM) and very low expression (<2 TPM) across oocyst stages and enteroepithelial stages.</td>
<td>5A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/30728393">Ramakrishnan et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_749cb10dcf" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_749cb10dcf&default=1"/></td>
<td>Stage-specific RNA-sequencing in Toxoplasma gondii</td>
<td class="human-readable">This gene is dramatically upregulated in bradyzoites compared to tachyzoites, with expression increasing over 3000-fold during stage conversion from the acute to chronic form in <i>Toxoplasma gondii</i>.</td>
<td>5A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/31955846">Waldman et al.</a></td>
<td>RNA-Seq</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>Strain-dependent expression variation in tachyzoites</h2>
      <p class="human-readable">Expression shows remarkable variation across different <i>T. gondii</i> strains, with some strains showing high expression while others have virtually undetectable levels, suggesting strain-specific regulatory mechanisms.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_485e6e94e3" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_485e6e94e3&default=1"/></td>
<td>Transcriptomes of 29 strains during murine macrophage infection</td>
<td class="human-readable">This gene shows highly variable expression across the 29 <i>Toxoplasma gondii</i> strains, with extremely high expression in CAST (103.58 TPM), B41 (70.86 TPM), and RAY (61.56 TPM) strains, while being virtually undetected in several strains including BOF, RH delta HXGPRT, and VEG (0 TPM).</td>
<td>4A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/22847430">Minot et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_73d06a9e7b" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_73d06a9e7b&default=1"/></td>
<td>Expression profiling of 3 archetypal lineages</td>
<td class="human-readable">This gene shows markedly higher expression in <i>T. gondii</i> Type III strains compared to Type I and Type II strains, with VEG strain exhibiting particularly strong upregulation (75.7th percentile).</td>
<td>4B</td>
<td>Davis and Roos, unpublished</td>
<td>array</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>MORC-mediated gene silencing controls expression</h2>
      <p class="human-readable">The gene is dramatically upregulated (200-600 fold) following MORC knockdown, indicating it is normally silenced by MORC-mediated chromatin regulation in tachyzoites.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_79e1396920" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_79e1396920&default=1"/></td>
<td>RNA-Seq of MORC WT and MORC KD parasites</td>
<td class="human-readable">This gene is dramatically upregulated in <i>Toxoplasma gondii</i> following MORC knockdown treatment, with expression increasing from baseline levels of ~0.5-2 TPM to 300-400 TPM after 24-48 hours of IAA treatment, and also shows substantial upregulation with FR235222 treatment in wild-type parasites.</td>
<td>5A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/32094587">Farhat et al.</a></td>
<td>RNA-Seq</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>Other</h2>
      <p class="human-readable">These experiments were not grouped by the AI.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_78959dea55" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_78959dea55&default=1"/></td>
<td>Tachyzoite Transcriptome Time Series (VEG)</td>
<td class="human-readable">This gene shows high expression early in <i>T. gondii</i> tachyzoite infection (136.19 TPM at 2 hours) that gradually decreases over time to low levels by 44 hours post-infection (17.67 TPM), indicating downregulation during the infection time course.</td>
<td>4B</td>
<td>Gregory</td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_4362334059" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_4362334059&default=1"/></td>
<td>Parasite transcriptome during infection in mouse brain.</td>
<td class="human-readable">This gene is highly expressed specifically in <i>Toxoplasma gondii</i>-infected neurons (TINs) with type II parasites showing ~8-fold higher expression than type III parasites, while being completely absent in bystander neurons.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/32878927">Merritt et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_4a81d92b98" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_4a81d92b98&default=1"/></td>
<td>RNA-Seq of CPSF4 WT and CPSF4 KD parasites</td>
<td class="human-readable">This gene shows substantial upregulation in <i>Toxoplasma gondii</i> following CPSF4 knockdown, with sense transcript levels increasing 13-20 fold from baseline (0.45 TPM) to 5.87-9.32 TPM across all auxin treatment timepoints (7h, 24h, 48h).</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/34263725">Farhat et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_c1a3dbb014" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_c1a3dbb014&default=1"/></td>
<td>Cell Cycle Expression Profiles (RH)</td>
<td class="human-readable">This gene shows a gradual upregulation throughout the <i>Toxoplasma gondii</i> cell cycle, with expression levels increasing approximately 1.9-fold from the lowest point (0-1 hours) to the peak at 12 hours post-thymidine synchronization.</td>
<td>3B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/20865045">Behnke et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_d459caa7da" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_d459caa7da&default=1"/></td>
<td>Tachyzoite transcriptome during invasion (RH)</td>
<td class="human-readable">This gene shows moderate upregulation in <i>Toxoplasma gondii</i> tachyzoites immediately after invasion of host cells (4.01 vs 3.5 log2 expression), with expression remaining elevated at 2 hours post-invasion (3.96).</td>
<td>3B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/21166903">Gaji et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_ef984802b1" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_ef984802b1&default=1"/></td>
<td>Tachyzoite Transcriptome Time Series (GT1)</td>
<td class="human-readable">This gene shows early peak expression in <i>T. gondii</i> tachyzoites with highest transcript levels at 4 hours post-infection (25.43 TPM) followed by a decline to minimal levels by 16 hours (1.1 TPM), indicating transient early infection-stage expression.</td>
<td>3B</td>
<td>Gregory</td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_94e899930e" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_94e899930e&default=1"/></td>
<td>Tachyzoite Transcriptome 3 and 4 days post-infection (VEG NcLIV)</td>
<td class="human-readable">This gene shows moderate upregulation in <i>T. gondii</i> tachyzoites from day 3 to day 4 post-infection, with expression levels increasing approximately 3.6-fold (from 1.75 to 6.3 TPM for unique reads).</td>
<td>3B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/22457617">Reid et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_59fb8debdb" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_59fb8debdb&default=1"/></td>
<td>T. gondii during infection in IEC18 cells (Dual RNA-Seq)</td>
<td class="human-readable">This gene shows specific expression in <i>Toxoplasma gondii</i> tachyzoites (3.47 TPM, 21.67th percentile) but is not expressed in sporozoites or frozen sporozoite controls, indicating stage-specific regulation during infection of rat intestinal epithelial cells.</td>
<td>3B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/28362800">Guiton et al. 2017</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_3a839edb9c" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_3a839edb9c&default=1"/></td>
<td>Transcriptome of Wild-Type and gra18 mutant strains of T. gondii</td>
<td class="human-readable">This gene shows higher expression in wild-type <i>T. gondii</i> Pru-infected samples (1.07-1.53 TPM) compared to both GRA18 knockout and complemented strains (0.31-0.78 TPM), with the pattern maintained across both non-LPS and LPS-stimulated conditions.</td>
<td>3B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/30320549">He et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_e8c4cf2187" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_e8c4cf2187&default=1"/></td>
<td>Differential Expression Profiling GCN5-A mutant</td>
<td class="human-readable">This gene shows moderate downregulation under alkaline stress conditions in both wild-type and GCN5-A knockout <i>Toxoplasma gondii</i>, with expression decreasing from ~4.4 to ~3.9 log2 units, and the response is largely maintained in the knockout strain.</td>
<td>2B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/21179246">Naguleswaran et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_d5645bc639" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_d5645bc639&default=1"/></td>
<td>Tachyzoite Transcriptome Time Series (ME49)</td>
<td class="human-readable">This gene shows low-level expression in <i>Toxoplasma gondii</i> tachyzoites with a notable early peak at 2 hours post-infection (2.73 TPM) followed by decreased expression through the remainder of the 44-hour time course.</td>
<td>2B</td>
<td>Gregory</td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_408f2c4cda" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_408f2c4cda&default=1"/></td>
<td>Bradyzoite in vitro Transcriptome (ME49)</td>
<td class="human-readable">This gene shows moderate expression in <i>Toxoplasma gondii</i> bradyzoites with 85.11 TPM in the sense orientation, ranking at the 78th percentile compared to all genes in the experiment.</td>
<td>2B</td>
<td>Sibley/Gregory</td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_a48cc7c61e" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_a48cc7c61e&default=1"/></td>
<td>Comparative ribosome profiling of intracellular and extracellular parasites</td>
<td class="human-readable">This gene shows very low expression with minimal transcript abundance (0.5 TPM) detected only in extracellular <i>Toxoplasma gondii</i> parasites, while being essentially absent in intracellular parasites across both RNA-seq and ribosome profiling conditions.</td>
<td>2B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/29228904">Hassan et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_930295d0b5" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_930295d0b5&default=1"/></td>
<td>T gondii Transcriptome during infection in 4 mouse cell types</td>
<td class="human-readable">This gene shows very low expression across all tested mouse cell types infected with <i>T. gondii</i>, with detectable transcript levels only in neurons (0.39 TPM, 14th percentile) and absent or near-zero expression in skeletal muscle cells, astrocytes, and fibroblasts.</td>
<td>2B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/28775382">Swierzy et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_6529b4f68d" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_6529b4f68d&default=1"/></td>
<td>Tachyzoite Transcriptome Time Series (RH)</td>
<td class="human-readable">This gene shows late-stage upregulation in <i>T. gondii</i> tachyzoites, with expression appearing only at 22 and 36 hours post-infection, particularly on the antisense strand at the final timepoint.</td>
<td>2C</td>
<td>Gregory</td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_72dce52949" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_72dce52949&default=1"/></td>
<td>Oocyst Time Series (M4)</td>
<td class="human-readable">This gene shows low expression levels throughout oocyst development in <i>Toxoplasma gondii</i>, with sense transcript expression increasing modestly from day 0 to days 4 and 10 (0 to ~1.3 TPM), while antisense expression remains consistently low and variable.</td>
<td>2C</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/22347997">Fritz/Boothroyd/Gregory</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_1bdad09720" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_1bdad09720&default=1"/></td>
<td>PMRT1 KO, WT and KOCM expression profiles</td>
<td class="human-readable">This gene shows minimal expression changes across wild-type, PRMT1 knockout, and complemented <i>Toxoplasma gondii</i> strains, with expression values remaining relatively stable (4.24, 4.21, and 3.91 log2 units respectively).</td>
<td>1B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/26838719">El Bissati et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_95bf119b5c" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_268860&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_95bf119b5c&default=1"/></td>
<td>RNA-seq of tartrolon E-treated T. gondii RH parasites</td>
<td class="human-readable">This gene shows very low expression levels (0-0.93 TPM) across all conditions in tartrolon E-treated <i>Toxoplasma gondii</i> parasites, with no clear dose- or time-dependent response pattern and no substantial differential expression between treatments and controls.</td>
<td>1B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/32738587">Bowden et al. 2020</a></td>
<td>RNA-Seq</td>
</tr>
        </tbody>
      </table>
    </section>
  
</body>
<footer>
<p>Generated by the <a href="https://github.com/VEuPathDB/expression-shepherd">Expression Shepherd</a> at commit <a href="https://github.com/VEuPathDB/expression-shepherd/commit/32699ea" target="_blank">32699ea</a> on Sat Jul 19 2025 14:08:22 GMT+0100 (British Summer Time)</p>
</footer>
</html>
  